A comprehensive test measuring kidney function markers including creatinine, urea, and uric acid. Used to assess renal status and kidney disease progression.
Manufactured by
China
Hangzhou Lysun Biotechnology Co., Ltd. is a biomedical company specializing in in-vitro diagnostic reagents and medical instruments, established in 2018. The company holds EN ISO 13485:2016 certification and CE marking, with over 20 patents. Lysun focuses on POCT products for self-testing, clinical biochemistry, and immunology, including COVID-19 antibody and antigen detection kits approved for export to multiple countries.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Ningbo Masschip Intelligent Technology Co., Ltd.
China · 3 relevant products
FIRSTLAB
Brazil · 1 relevant product
TMD LAB CO., LTD.
South Korea · 2 relevant products
Bioantibody Biotechnology Co., Ltd.
China · 8 relevant products
CareforU Co., Ltd.
South Korea · 2 relevant products
Beijing O&D Biotech Co., Ltd.
China · 1 relevant product
Chongqing BIOSTEC Biotechnology Co., Ltd
China · 4 relevant products
Anbio Biotechnology Limited
Germany · 5 relevant products
Bio Preventive Medicine Co. Ltd.
Taiwan · 4 relevant products
STRATEC/Diatron
Germany · 3 relevant products
57 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 104 closest product alternatives
Ningbo Masschip Intelligent Technology Co., Ltd. · China
Measurement of kidney function markers including creatinine and urea. Essential for assessing renal disease and drug dosing.
FIRSTLAB · Brazil
Laboratory test panel for evaluating kidney function and assessing renal disease. Includes multiple analytes for comprehensive renal assessment.
TMD LAB CO., LTD. · South Korea
Tests measuring creatinine, blood urea nitrogen, and glomerular filtration rate. Assesses renal function and monitors kidney disease progression.
Bioantibody Biotechnology Co., Ltd. · China
Quantitative test measuring renal function markers including creatinine and electrolytes. Assesses kidney functionality and detects renal impairment.
CareforU Co., Ltd. · South Korea
Comprehensive in vitro diagnostic testing panel for assessment of kidney function and detection of renal disease. Includes measurement of relevant biomarkers and clinical parameters.
Beijing O&D Biotech Co., Ltd. · China
Chemiluminescence immunoassay for renal function markers and kidney disease assessment. Supports evaluation of glomerular filtration and renal dysfunction. Part of the company's comprehensive chemiluminescence product portfolio.
Ningbo Masschip Intelligent Technology Co., Ltd. · China
Comprehensive analysis of hepatic function markers including enzymes and bilirubin. Used for liver disease diagnosis and monitoring.
Chongqing BIOSTEC Biotechnology Co., Ltd · China
Specialized diagnostic panel for chronic kidney disease detection and monitoring. Focuses on early identification of kidney dysfunction through specific protein biomarker analysis.
Bioantibody Biotechnology Co., Ltd. · China
Comprehensive quantitative test assessing hepatic enzyme and protein levels. Evaluates liver function and detects hepatic disorders.
Anbio Biotechnology Limited · Germany
Assay panel including creatinine and urea measurements for renal function evaluation. Monitors kidney disease progression and medication safety.
TMD LAB CO., LTD. · South Korea
Comprehensive testing module measuring hepatic enzymes and bilirubin levels. Evaluates liver synthetic function and hepatocellular integrity.
Bio Preventive Medicine Co. Ltd. · Taiwan
A comprehensive biomarker diagnostic panel for assessing the progression risk of diabetic kidney disease and predicting end-stage kidney disease development. The test utilizes novel biomarker technologies to stratify patient risk and guide personalized treatment decisions.
92 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products